US49720K2006 - Common Stock
What's going on in today's after hours session
Kintara Therapeutics just reported results for the third quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kintara Therapeutics (NASDAQ:KTRA) just reported results for the third quarter ...
/PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law...
It's time to dive into all of the biggest pre-market stock movers that traders will want to keep an eye on Friday morning!
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Ademi LLP is investigating Kintara (Nasdaq: KTRA) for possible breaches of fiduciary duty and other violations of law in its transaction with...
Costco is offering a new weight loss program for subscribers that may also include prescriptions for weight loss drug Ozempic.
Vanda Pharmaceuticals stock is rising higher on Wednesday as investors in VNDA celebrate FDA approval of its bipolar treatment.
Kintara Therapeutics stock is rising higher on Wednesday as KTRA investors react to a merger plan with TuHURA Biosciences.
TuHURA is planning to advance a single Phase 3 trial for IFx-2.0 personalized cancer vaccine as adjunctive therapy with Keytruda® in first-line therapy for...
Pre-market stock movers are a hot topic on Thursday as we check out all of the biggest stories moving shares this morning!